Net Asset Value(s)

Valuation dated 2026-02-05 for LISTD PRIVTE EQTY UCITS (ISIN IE0008ZGI5C1) shows 10,837,022.0000 units with a NAV per unit of USD 31.1698. The update implies an aggregate NAV of approximately USD 337.8 million, providing a current mark-to-market valuation for investors in this listed private equity UCITS.

Analysis

Market structure: The single NAV print (NAV/unit $31.1698; implied AUM ≈ $338M) signals a mid-sized UCITS wrapper providing retail access to private equity—winners are listed private equity managers (BX, KKR, APO) and ETFs that arbitrage discounts; losers are late-cycle VC/illiquid pre-IPO holders if secondary markets remain weak. Pricing power shifts toward large GP balance sheets and secondaries buyers who can offer liquidity; expect persistent NAV-to-market discounts of 10–30% when public exit windows narrow over the next 3–12 months.

Risk assessment: Key tail risks are abrupt NAV markdowns from a stop in IPO/M&A activity (20–40% downside in stressed scenarios), sudden redemption runs in UCITS causing forced sales, and FX swings if USD strengthens >3% vs EUR in 30 days. Immediate (days) impact is minimal; short-term (weeks–months) risk centers on discount widening and secondary pricing; long-term (quarters–years) depends on exit volume and credit conditions. Hidden dependencies include GP leverage, hurdle-rate waterfalls and gate provisions—monitor quarterly reports and GPs’ debt covenants.

Trade implications: Favor listed private-equity exposure vs illiquid venture names: long PSP or BX/KKR for 6–18 months to capture fee resilience and discount compression; hedge with short high-beta small-cap growth (ARKK or IWM-small caps) to protect versus public re-rating. Use options to define risk: buy 3–6 month 10% OTM call spreads on BX/KKR to capture upside if discounts compress, and protective put collars when NAV discounts exceed 20%.

Contrarian angle: Consensus underestimates persistence of distributable NAV and fee income—large GPs can sustain dividends even with mark-to-market softness, creating a potential mispricing if public investors panic. The overreaction risk: temporary discounts >20% may offer a 12–18 month asymmetric return (target 25–40% upside if IPO/M&A activity normalizes). Unintended consequence: buying listed PE exposes you to public cyclical beta (tech IPOs, credit spreads), so size positions modestly and pair-hedge.

Key Decisions for Investors

• Establish a 2–3% portfolio position in Invesco Global Listed Private Equity ETF (PSP) within 0–3 months if secondary-market discounts to reported NAV exceed 15%; target hold 12–18 months, stop-loss at 30% drawdown, take-profit at 25–40% gain.
• Allocate 1–1.5% long each to Blackstone (BX) and KKR (KKR) on strength in credit markets within 6–12 months; hedge by shorting 1.5–2% exposure to ARK Innovation ETF (ARKK) or the Russell 2000 (IWM) to reduce public-market beta.
• Implement defined-risk options: buy 3–6 month call spreads (10% OTM) on BX/KKR sized to 1% portfolio risk to capture discount compression; if holding listed PE and NAV discount >20%, purchase 3-month ATM puts (cost-funded by selling 20–30% OTM calls) as a collar.
• Reduce direct exposure to pre-IPO VC-heavy equities and small-cap tech by 2–4% over the next 30–90 days, reallocating proceeds to listed PE or credit (senior CLO tranches) if investment-grade credit spreads tighten <50bp from current levels.
• Monitor weekly NAV publications, reported AUM and any investor gate/redemption notices; trigger re-evaluation if (a) fund NAV is cut >10% QoQ, (b) implied discount widens >20%, or (c) IPO/M&A deal count drops >30% QoQ—act within 5 trading days of trigger.